Literature DB >> 3920315

Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).

V Pistoia, F Cozzolino, M Torcia, E Castigli, M Ferrarini.   

Abstract

The present study reports the characterization of a non-T cell from human peripheral blood which is capable of releasing BCGF. This BCGF-producing non-T cell had a T3-, T8-, Leu-7+, OKM1+, HLA-DR-, Leu-11- surface phenotype and was likely to belong to the so-called large granular lymphocyte (LGL) subset because: after fractionation of non-T cells according to the expression of Leu-7 or HLA-DR markers, it was found in the Leu-7+, HLA-DR- fractions that were particularly enriched in LGL; it co-purified with LGL on Percoll density gradients; and it expressed Leu-7 and OKM1 markers that are shared by a large fraction of LGL. Although co-purified with cells with potent NK capacities, the BCGF-producing cell was not cytotoxic, because treatment of Leu-7+ cells with Leu-11 monoclonal antibody and complement abolished the NK activity but left the BCGF activity unaltered. The factor released by this LGL subset was not IL 1 or IL 2 mistakenly interpreted as BCGF, because: a) cell supernatants particularly rich in BCGF activity contained very little or no IL 1 or IL 2; b) BCGF-induced B cell proliferation was not inhibitable by anti-Tac antibodies (this in spite of the expression of IL 2 receptor by a proportion of activated B cells); and c) BCGF activity was absorbed by B but not T blasts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920315

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Suppressive role of NK cells in pokeweed mitogen-induced immunoglobulin synthesis: effect of depletion/enrichment of Leu 11b+ cells.

Authors:  P D Mason; A P Weetman; J G Sissons; L K Borysiewicz
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

2.  Gamma-interferon production by human low-density lymphocytes induced by T-cell mitogens.

Authors:  A D Croll; M F Wilkinson; A G Morris
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

3.  Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes.

Authors:  C F Brooks; M Moore
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis.

Authors:  M A Rodriguez; I Blanca; M L Baroja; S Arama; M Leon-Ponte; I Abadi; N E Bianco
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

5.  Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

Authors:  J Z Wimperis; M K Brenner; H G Drexler; A V Hoffbrand; H G Prentice
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

6.  Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populations.

Authors:  V Pistoia; A J Carroll; E F Prasthofer; A B Tilden; K S Zuckerman; M Ferrarini; C E Grossi
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

7.  Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.

Authors:  H Kimata; E H Sherr; A Saxon
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

8.  Heterogeneity of human blood monocyte: two subpopulations with different sizes, phenotypes and functions.

Authors:  S Y Wang; K L Mak; L Y Chen; M P Chou; C K Ho
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

9.  Lesional modulation of peripheral monocyte leucotactic responsiveness in leprosy.

Authors:  P B Campbell; T A Tolson; L Yoder; J Loesch; J L Krahenbuhl
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

10.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.

Authors:  J D Gray; A Lash; A C Bakke; R C Kitridou; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.